NUZ neurizon therapeutics limited

Ann: First Patient of Cohort 2 Dosed in MND Trial, page-2

  1. 1,121 Posts.
    lightbulb Created with Sketch. 215
    It sounds like patients have only been recruited from the Melbourne site so far, things might pickup pace when Sydney get up and running.

    “The trial is overseen by Dr Susan Mathers of Calvary Health Care, Bethlehem, Statewide Progressive Neurological Disease Service, Melbourne and will include a second trial site headed by Professor Dominic Rowe of the Centre for Motor Neurone Disease Research Faculty of Medicine and Health Research at Macquarie University, Sydney.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
15.5¢
Change
0.000(0.00%)
Mkt cap ! $76.30M
Open High Low Value Volume
15.5¢ 16.5¢ 15.5¢ $32.40K 206.9K

Buyers (Bids)

No. Vol. Price($)
5 37701 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 355395 7
View Market Depth
Last trade - 15.55pm 08/07/2025 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.